Using of Extracorporeal Shockwave Therapy in Treatment Of Achilles Tendinopathy

Using of Extracorporeal Shockwave Therapy in Treatment Of Achilles Tendinopathy

The purpose of this study was to determine the effect of extracorporeal Shock wave therapy (ESWT) on functional activity and pain in patients with Achilles tendinopathy

Fifty patients of both sexes with Achilles tendinopathy aged 18-40 years, were assigned randomly into two equal groups. The study group received ESWT in addition to a conservative physical therapy program for four weeks, while the control group received a conservative physical therapy program only. Pain and functional mobility were assessed before and after treatment through a visual analog scale (VAS) and Victorian Institute of sports assessment - Achilles questionnaire (VISA-A), respectively

Inclusion criteria

• Clinical history of Achilles tendon pain for at least six months
• A minimum of three months conservative treatment administered without benefit for at least four weeks before ESWT.

Exclusion Criteria:

• Patients underwent physical therapy in the four weeks prior enrollment to study.
• Patients had taken non-steroidal anti-inflammatory medication during the previous week
• Patients had received peritendinous injections of a local anesthetic or corticosteroid within last 4 weeks
• Patients had bilateral Achilles tendinopathy
• Patients with other conditions that could significantly contribute to posterior ankle pain (osteoarthritis, radiculopathy, systemic neurologic conditions)
• Patients having previous injury or surgical treatments of the ankle.